Next-Generation Inflammatory Response Assay: Advancing Cytokine And Immune Cell Characterization For Precision Bioanalysis

Inflammation is a key driver in a wide range of diseases—including autoimmune conditions, infections, and immune-related side effects from immunotherapy — and accurately assessing it is essential for understanding disease mechanisms, monitoring therapeutic efficacy, and identifying new targets. Traditional cytokine assays often fall short by lacking the cellular context needed to fully capture immune dynamics. Because inflammatory responses are shaped by complex cytokine networks and immune cell interactions, they require a more integrated, high-resolution analytical approach. Our next-generation inflammatory response assay addresses this need by simultaneously profiling cytokines and immune cell phenotypes, generating multi-dimensional data that advances both translational research and clinical decision-making. This platform enables:

• Precise assessment of cytokine-driven immune regulation
• Identification of immune cell populations driving inflammation or suppression
• Discovery of novel biomarker signatures linked to disease progression or therapeutic response

These insights can profoundly influence areas such as immuno-oncology, autoimmune disease research, and vaccine development — paving the way for more targeted, effective therapies tailored to individual immune profiles.